STOCK TITAN

Cardinal Health (NYSE: CAH) grants 2,610 performance share units to CAO

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Scherer Mary C. reported acquisition or exercise transactions in this Form 4 filing.

Cardinal Health Inc.'s Chief Accounting Officer Mary C. Scherer received a grant of 2,610 performance share units on August 4, 2026, at a stated price of $0.0000 per unit. These units will settle into common shares on August 15, 2026, bringing her reported direct holdings to 6,105 common shares.

Positive

  • None.

Negative

  • None.
Insider Scherer Mary C.
Role Chief Accounting Officer
Type Security Shares Price Value
Grant/Award Common Shares F1 2,610 $0.00 $0.00
Holdings After Transaction: Common Shares — 6,105 shares (Direct)
Footnotes (1)
  1. F1. Reflects performance share units that will settle on August 15, 2026.
Performance share units granted 2,610 units Equity award to Chief Accounting Officer on August 4, 2026
Price per unit $0.0000 Stated transaction price per performance share unit
Total common shares following award 6,105 shares Reported direct holdings after the grant
Settlement date for units August 15, 2026 Date when performance share units will settle into common shares
performance share units financial
"Reflects performance share units that will settle on August 15, 2026."
Performance share units are a type of company stock award given to employees that depend on the company meeting specific goals or targets. If these goals are achieved, the employee receives shares or the value of shares; if not, they may receive little or no compensation. This aligns employees’ interests with the company's success and encourages performance that benefits investors.
Chief Accounting Officer financial
"officer_title: Chief Accounting Officer"
A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Cardinal Health (CAH) report for Mary C. Scherer?

Cardinal Health reported that Chief Accounting Officer Mary C. Scherer received a grant of 2,610 performance share units on August 4, 2026. These units are part of her equity compensation and are scheduled to settle into common shares on August 15, 2026.

How many Cardinal Health (CAH) units did Mary C. Scherer receive in this Form 4 filing?

Mary C. Scherer received 2,610 performance share units tied to Cardinal Health common shares. The award was recorded at a stated transaction price of $0.0000 per unit, reflecting an equity compensation grant rather than an open-market purchase or sale.

When will the performance share units granted to CAH executive Mary C. Scherer settle?

The performance share units will settle on August 15, 2026. At that time, they are scheduled to convert into Cardinal Health common shares, consistent with the equity award terms described, and will then be reflected in her share ownership position.

What is Mary C. Scherer’s reported Cardinal Health (CAH) share ownership after this award?

After this grant, Mary C. Scherer is reported to hold 6,105 Cardinal Health common shares directly. This figure includes the newly awarded performance share units, which are scheduled to settle into common shares on August 15, 2026, according to the footnote disclosure.

Was the Cardinal Health (CAH) equity grant to Mary C. Scherer an open-market transaction?

No. The filing characterizes the transaction as a grant or award acquisition of 2,610 performance share units at a stated price of $0.0000. This indicates compensation-related equity, not a purchase or sale executed in the open market.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Scherer Mary C.

(Last)(First)(Middle)
7000 CARDINAL PLACE

(Street)
DUBLIN OHIO 43017

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares08/04/2026A(1)2,610A$06,105D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects performance share units that will settle on August 15, 2026.
Remarks:
/s/ Laura C. Dhaliwal, Attorney-in-fact08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)